Telmisartan and Hydrochlorothiazide Tablets — Class III drug recall D-0285-2022
Terminated recall by Torrent Pharma Inc., reported 2021-12-22, distributed nationwide. Superpotent; Hydrochlorothiazide
| Recall number | D-0285-2022 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Torrent Pharma Inc., Basking Ridge, NJ, United States |
| Recall initiated | 2021-12-01 |
| Classified | 2021-12-16 |
| Reported by FDA | 2021-12-22 |
| Terminated | 2024-05-12 |
| Distributed | Nationwide (US) |
| Quantity | 27,312 bottles |
| Reason classes | potency |
| NDC | 13668-0159-30 |
| Lot numbers | BZ74G001 |
| Expiration dates | 2021-12 |
Product
Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-159-30
Reason for recall
Superpotent; Hydrochlorothiazide
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0285-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.